Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients.

Saved in:
Bibliographic Details
Title: Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients.
Authors: Kosmeri, Chrysoula1 (AUTHOR) chrisa.kosmeri@gmail.com, Baltogianni, Maria2 (AUTHOR) mbalt@doctors.org.uk, Giapros, Vasileios2 (AUTHOR) faybal18@yahoo.com, Siomou, Ekaterini1 (AUTHOR) eksiomou@uoi.gr, Tsinopoulou, Vasiliki-Regina3 (AUTHOR) vasotsino@gmail.com, Balomenou, Foteini2 (AUTHOR), Serbis, Anastasios1 (AUTHOR) tasos_serbis@yahoo.com
Source: Endocrines. Jun2024, Vol. 5 Issue 2, p214-224. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2673396X
DOI:10.3390/endocrines5020015